NCT06780319 Digital Rehabilitation After Hip Arthroplasty: a Randomized Controlled Trial
| NCT ID | NCT06780319 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique du Sport, Bordeaux Mérignac |
| Condition | Hip Arthroplasty, Total |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-06-04 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-06-04 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to compare the effectiveness of tele-rehabilitation versus no physical therapy after total hip arthroplasty (THA) in improving patient-reported outcomes and functional recovery. THR is a common surgical procedure to relieve pain and improve function in patients with a variety of hip conditions. Traditional physical therapy is a standard component of the post-operative care pathway for PTH patients, but can be hampered by logistical obstacles. Tele-rehabilitation is emerging as a promising alternative, offering the potential to overcome these barriers and improve access to care. The study uses a prospective monocentric design with two arms and a follow-up time of 6 months. The primary objective is assessed using the Timed up and go Test (TUG), while secondary objectives include patient-reported outcome measures, patient satisfaction, healthcare utilization, and return to physical activity.
Eligibility Criteria
Inclusion Criteria: * Have an email address and a smartphone * Patient speaking and writing French * Patient covered by a social security scheme Exclusion Criteria: * Hip revision surgery, significant comorbidities (Parkinson's disease, multiple sclerosis, stroke) or psychiatric disorders (substance use) that could interfere with rehabilitation * Patients with disorders that make it difficult for them to express their feelings * Pregnant or breast-feeding patients * Patient under protective supervision * Patient not covered by a social security scheme
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06780319 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Hip Arthroplasty, Total. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06780319 currently recruiting?
Yes, NCT06780319 is actively recruiting participants. Contact the research team at pierre.laboudie@gmail.com for enrollment information.
Where is the NCT06780319 trial being conducted?
This trial is being conducted at Mérignac, France.
Who is sponsoring the NCT06780319 clinical trial?
NCT06780319 is sponsored by Clinique du Sport, Bordeaux Mérignac. The trial plans to enroll 60 participants.